Table 1 Baseline and clinicopathalogical characteristics of GBC patients (N = 176)
From: Survival analysis and prognostic factors of the carcinoma of gallbladder
Variable | Item | N (%) |
|---|---|---|
Age | 26–45 | 45 (25.6) |
45–65 | 131 (74.4) | |
Gender | Female | 126 (71.6) |
Male | 50 (28.4) | |
Region | Rural | 148 (84.1) |
Urban | 28 (15.9) | |
Dietary habit | Vegetarian | 146 (83.0) |
Nonvegetarian | 30 (17.0) | |
Tobacco chewing | Non-chewer | 90 (51.1) |
Chewer | 86 (48.9) | |
Jaundice | Absent | 72 (40.9) |
Present | 104 (59.1) | |
Gallstones | Absent | 51 (29.0) |
Present | 125 (71.0) | |
Liver infiltration | Absent | 34 (19.3) |
Present | 142 (80.7) | |
Any chronic disease | Absent | 145 (82.4) |
Present | 31 (17.6) | |
Histology | Adenocarcinoma | 158 (89.8) |
Non-adenocarcinoma | 18 (10.2) | |
Grade | I/II | 105 (59.7) |
III/IV | 71 (40.3) | |
Tumor location | Fundus | 106 (60.2) |
Body-neck | 70 (39.8) | |
Clinical stage | I/II | 32 (18.2) |
III/IV | 144 (81.8) | |
T stage | T1/T2 | 50 (28.4) |
T3/T4 | 126 (71.6) | |
N stage | N0 | 83 (47.2) |
N1/N2 | 93 (52.8) | |
M stage | M0 | 68 (38.6) |
M1 | 108 (61.4) | |
Surgery | No | 133 (75.6) |
Yes | 43 (24.4) | |
Radiation | No | 159 (90.3) |
Yes | 17 (9.7) | |
Chemotherapy | No | 17 (9.7) |
Yes | 159 (90.3) | |
Chemotherapy regimens | Gemcitabine + cisplatin | 152 (86.4) |
Gemcitabine + carboplatin | 16 (9.1) | |
Nill | 8 (4.5) |